Literature DB >> 22248723

Immune outcomes of paradoxical sleep deprivation on cellular distribution in naive and lipopolysaccharide-stimulated mice.

Adriano Zager1, Francieli Silva Ruiz, Sergio Tufik, Monica Levy Andersen.   

Abstract

BACKGROUND/AIMS: Several lines of evidence indicate that sleep loss imposes significant consequences on the host defense system, including changes in cell number, activity and distribution. However, it is not clear whether cellular alterations after sleep deprivation are caused by redistribution to immune organs or by death of these cells or how the response to a nonspecific immune activator would be affected. Therefore, the aim of this study was to assess the leukocyte distribution after paradoxical sleep deprivation (PSD) in saline- and lipopolysaccharide-treated mice.
METHODS: Adult inbred mice were paradoxical sleep deprived (72 h), whereas the controls were kept in their home cages. After PSD, both groups received an injection of either saline or lipopolysaccharide (LPS; 1 or 5 μg/animal, intraperitoneally), 2 h prior to the collection of blood, spleen, lymph nodes and peritoneal wash. Isolated cells were then designated to differential leukocyte count (blood) and flow cytometry analysis of immune cell subsets (immune sites).
RESULTS: The data revealed that PSD caused a significant reduction of circulating lymphocytes and a general decrease in all cellular subsets of spleen, mainly T and B cells. However, no alteration in response of PSD was found on other immune sites, such as lymph nodes and peritoneum. Of note, immune cell distribution in response to in vivo LPS stimulation remained unchanged after PSD.
CONCLUSIONS: Our study provided original evidence concerning the immune outcomes of PSD, indicating that cellular decrease caused by PSD is not restricted to circulation, but also to immune sites. Taken together, our results could help shed light on the physiological mechanisms of leukocyte trafficking.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22248723     DOI: 10.1159/000329484

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  6 in total

Review 1.  GOODNIGHT, SLEEP TIGHT, DON'T LET THE MICROBES BITE: A REVIEW OF SLEEP AND ITS EFFECTS ON SEPSIS AND INFLAMMATION.

Authors:  Wendy E Walker
Journal:  Shock       Date:  2022-08-08       Impact factor: 3.533

Review 2.  Sick and tired: how molecular regulators of human sleep schedules and duration impact immune function.

Authors:  Philip A Kurien; S Y Christin Chong; Louis J Ptáček; Ying-Hui Fu
Journal:  Curr Opin Neurobiol       Date:  2013-05-20       Impact factor: 6.627

3.  Lipopolysaccharide-induced inflammation does not alter muscle spindle afferent mechanosensation or sensory integration in the spinal cord of adult mice.

Authors:  Dasha Zaytseva; Anusha Allawala; Joy A Franco; Shea Putnam; Adam M Abtahie; Nina Bubalo; Connor R Criddle; Tuan A Nguyen; Peter Nguyen; Shreejit Padmanabhan; Puneet Sanghera; Martina Bremer; Tzvia Abramson; Katherine A Wilkinson
Journal:  Physiol Rep       Date:  2018-09

4.  Sleep Deprivation Alters the Pituitary Stress Transcriptome in Male and Female Mice.

Authors:  Mario G Oyola; Elizabeth A Shupe; Anthony R Soltis; Gauthaman Sukumar; Marcelo Paez-Pereda; Darwin O Larco; Matthew D Wilkerson; Stephen Rothwell; Clifton L Dalgard; T John Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

5.  Sleep Deprivation Disturbs Immune Surveillance and Promotes the Progression of Hepatocellular Carcinoma.

Authors:  Jing Huang; Peiwen Song; Kaibin Hang; Zeka Chen; Zidan Zhu; Yuye Zhang; Jietian Xu; Jie Qin; Binghua Wang; Weimin Qu; Zhili Huang; Chunmin Liang
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

6.  Sleep loss and cytokines levels in an experimental model of psoriasis.

Authors:  Camila Hirotsu; Mariana Rydlewski; Mariana Silva Araújo; Sergio Tufik; Monica Levy Andersen
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.